The ACTRIMS Forum 2023, San Diego, California, Conference Date: 2023/2
Risk of Multiple Sclerosis in People with HIV: An International Cohort study.
Authors: E. Kingwell, A. Manouchehrinia, F. Zhu, K. McKay, J. Li, M. Ye, P. Sereda, J. Trigg, K. Kooij, M. Gisslén, A. Ekström, J. Hillert, R. Hogg, H. Tremlett.
Presentation Type: Oral Presentation – Session 3 – Impact of COVID-19 and Other Pathogens on MS
Media coverage:
HIV-positive people found to be less likely to develop MS (posted March 1st 2023)
Understanding the Risk of Multiple Sclerosis in Patients with HIV (posted March 28th 2023)
Psychiatric Morbidity in Multiple Sclerosis During the Prodromal Period
Authors: A. Chertcoff, F. L. Yusuf, F. Zhu, C. Evans, J. D. Fisk, Y. Zhao, R. Marrie, H. Tremlett.
The American Academy of Neurology (in partnership with the Americas Committee for Treatment and Research in MS) Annual Meeting in Boston, MA, April 22 – 27, 2023.
Awards:
ACTRIMS Educational Grant as a Young Investigator with
a highly rated abstract accepted for oral presentation. The Educational Grant includes a $600 USD stipend to use in support of participation at the ACTRIMS Forum 2023.
National MS Society’s ECHO MS Continuing Education scholarship,
$US1500 for travel Selected by ACTRIMS as a Best Young Investigator Oral Presentation
Media Coverage
High Level of Psychiatric Morbidity in Prodromal MS Medscape Neurology interview, posted 27 Feb 2023
Anxiety, depression more common in MS before onset
Psychiatric visits 146% higher for patients in year before MS onset
